FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2044710086> ?p ?o ?g. }

• W2044710086 abstract "Since William Dameshek has described the concept of myeloproliferative disorders (MPD) by identifying common clinical characteristics (i.e. hemorrhage, thrombosis and leukemic transformation) of polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF), the advent of molecular biology has provided substantial molecular insight into the pathobiology of myeloproliferative neoplasia (MPN). Recently, the description of the gain-of-function mutation of JAK2 (JAK2V617F) has been identified in classical Philadelphia (Ph)-negative MPN, thus providing a rational target for novel innovative treatment strategies. In addition, molecular characterization of atypical Ph-negative MPN (e.g. the KITD816V mutation in mastocytosis and PDGF-receptor rearrangements in hypereosinophilic syndromes/chronic eosinophilic leukemia) complement the molecular knowledge of this heterogeneous disease family. Currently, clinical studies testing various JAK2-inhibitors in PV, ET as well as in primary and secondary myelofibrosis (MF) are under way. Interestingly, first data indicate that despite marked clinical activity in terms of spleen size reduction and improvement of constitutional symptoms, these inhibitors might not sufficiently reduce disease burden. Thus, alternative and well established treatment strategies, such as inhibition of thrombocyte aggregation by low dose aspirin, cytotoxics (e.g. hydroxyurea), immuno- and stroma-modifying therapy with interferon, tyrosine kinase inhibitors and, in selected cases, allogeneic stem cell transplantation are still important treatment options for patients suffering from MPN, which will be discussed in detail in this review." @default.
• W2044710086 created "2016-06-24" @default.
• W2044710086 creator A5013627281 @default.
• W2044710086 creator A5032138074 @default.
• W2044710086 creator A5086213188 @default.
• W2044710086 date "2011-01-01" @default.
• W2044710086 modified "2023-09-25" @default.
• W2044710086 title "Current Treatment Concepts of Philadelphia-Negative MPN" @default.
• W2044710086 cites W1250526649 @default.
• W2044710086 cites W135049235 @default.
• W2044710086 cites W1535534106 @default.
• W2044710086 cites W1768890565 @default.
• W2044710086 cites W1963876174 @default.
• W2044710086 cites W1968468753 @default.
• W2044710086 cites W1972992877 @default.
• W2044710086 cites W1978652970 @default.
• W2044710086 cites W1981135441 @default.
• W2044710086 cites W1985177017 @default.
• W2044710086 cites W1987587843 @default.
• W2044710086 cites W1989167457 @default.
• W2044710086 cites W1993099484 @default.
• W2044710086 cites W1993230181 @default.
• W2044710086 cites W1998271419 @default.
• W2044710086 cites W1999025699 @default.
• W2044710086 cites W1999380519 @default.
• W2044710086 cites W1999682935 @default.
• W2044710086 cites W2000903716 @default.
• W2044710086 cites W2001426718 @default.
• W2044710086 cites W2001901845 @default.
• W2044710086 cites W2006734588 @default.
• W2044710086 cites W2007266721 @default.
• W2044710086 cites W2008952929 @default.
• W2044710086 cites W2008970948 @default.
• W2044710086 cites W2011098491 @default.
• W2044710086 cites W2012245921 @default.
• W2044710086 cites W2012828222 @default.
• W2044710086 cites W2012952884 @default.
• W2044710086 cites W2014316424 @default.
• W2044710086 cites W2015663870 @default.
• W2044710086 cites W2020085141 @default.
• W2044710086 cites W2025614458 @default.
• W2044710086 cites W2026965552 @default.
• W2044710086 cites W2030028624 @default.
• W2044710086 cites W2033319140 @default.
• W2044710086 cites W2033388083 @default.
• W2044710086 cites W2035060370 @default.
• W2044710086 cites W2036047439 @default.
• W2044710086 cites W2042453360 @default.
• W2044710086 cites W2049447930 @default.
• W2044710086 cites W2051456036 @default.
• W2044710086 cites W2055634090 @default.
• W2044710086 cites W2055961324 @default.
• W2044710086 cites W2056259700 @default.
• W2044710086 cites W2056773025 @default.
• W2044710086 cites W2064690570 @default.
• W2044710086 cites W2068158468 @default.
• W2044710086 cites W2069651950 @default.
• W2044710086 cites W2072691059 @default.
• W2044710086 cites W2075428599 @default.
• W2044710086 cites W2076401774 @default.
• W2044710086 cites W2077810015 @default.
• W2044710086 cites W2083755767 @default.
• W2044710086 cites W2090045594 @default.
• W2044710086 cites W2097056802 @default.
• W2044710086 cites W2097692898 @default.
• W2044710086 cites W2104233349 @default.
• W2044710086 cites W2105295922 @default.
• W2044710086 cites W2108300632 @default.
• W2044710086 cites W2110448885 @default.
• W2044710086 cites W2112316414 @default.
• W2044710086 cites W2116768113 @default.
• W2044710086 cites W2119160082 @default.
• W2044710086 cites W2121462692 @default.
• W2044710086 cites W2123587611 @default.
• W2044710086 cites W2123633897 @default.
• W2044710086 cites W2123973590 @default.
• W2044710086 cites W2127559749 @default.
• W2044710086 cites W2129219546 @default.
• W2044710086 cites W2129629467 @default.
• W2044710086 cites W2130858966 @default.
• W2044710086 cites W2139133547 @default.
• W2044710086 cites W2140648938 @default.
• W2044710086 cites W2142165201 @default.
• W2044710086 cites W2145829737 @default.
• W2044710086 cites W2149373649 @default.
• W2044710086 cites W2155591233 @default.
• W2044710086 cites W2155730304 @default.
• W2044710086 cites W2156954424 @default.
• W2044710086 cites W2159962994 @default.
• W2044710086 cites W2161254333 @default.
• W2044710086 cites W2163876274 @default.
• W2044710086 cites W2167405925 @default.
• W2044710086 cites W2229971338 @default.
• W2044710086 cites W2320032845 @default.
• W2044710086 cites W2341264142 @default.
• W2044710086 cites W2400429374 @default.
• W2044710086 cites W3023846844 @default.
• W2044710086 cites W3114368461 @default.
• W2044710086 cites W3190659723 @default.
• W2044710086 doi "https://doi.org/10.2174/156800911793743592" @default.

• next